samedan logo

 
 
spacer
home > ebr > spring 2003 > biotech companies in the pharma market - grow or be doomed, warns dr volker janssen, director at simon-kucher & partners
PUBLICATIONS
European Biopharmaceutical Review

Biotech Companies in the Pharma Market - Grow or be Doomed, warns Dr Volker Janssen, Director at Simon-Kucher & Partners

The German biotech industry is booming. According to a study carried out by management consultancy Ernst & Young, the number of biotech companies with less than 500 employees (this accounts for the majority of German biotechs) increased by more than 90 per cent between 1997 and 2000, which means there are now more than 300 biotech companies operating in Germany. The turnover generated by these companies has nearly tripled, as has the number of employees. In 2000, the Biotech Index on the Neuer Markt in Frankfurt was often quoted at 50 per cent above the NEMAX Allshare Index. In view of Germany's unparalleled growth in the biotech arena one was inclined to believe Deutsche Bank's forecasts for the sector: a turnover increase for SME

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Volker Janssen, Director at Simon-Kucher & Partners

Dr Volker Janssen is a Director in the Life Science division of Simon-Kucher & Partners Strategy & Marketing Consultants. He specialises in consulting to pharmaceutical clients, mainly in the areas of strategic marketing, corporate communications, sales force management, market segmentation, international pricing and value-to-customer.

He has worked for a number of companies in Europe, Japan and the US, including Aventis, Pfizer, Novo Nordisk, Fujisawa, Johnson & Johnson, Eli Lilly, 3M, Sanitec and DHL. Dr Janssen is the author of numerous publications on pricing, sales force management and communication and has spoken frequently at conferences and seminars on these subjects.

spacer
Dr Volker Janssen
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Finalists revealed for CPhI Worldwide’s eagerly anticipated 2019 Awards

London, 17th October 2019: CPhI Worldwide announces the finalists for the CPhI Pharma Awards. The shortlist spans 13 different categories across the full spectrum of the pharmaceutical supply chain, including Formulation, Packaging and Lifetime Achievement Awards.
More info >>

White Papers

Shipping with Active Packaging Containers: Three Pre-flight Decisions that Impact the Success of High-value Global Shipments

World Courier

It is the dead of winter in the northern hemisphere and the height of summer in the southern, with external temperature fluctuations exceeding 50 degrees. Flight delays have added precious days to the transport of your multi-million dollar shipment of blockbuster drug from South East Asia destined for Russia. In France, the roads are closed for days due to a monster snowstorm, with your irreplaceable shipment of investigational drugs stopped somewhere en route between Paris and the clinical trial site. Will all be lost, or can informed choices made before the shipment departs ensure product safety despite unforeseen circumstances?
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement